Involvement of bivalent histone modification in age-specific cancer susceptibility
Project/Area Number |
15K18420
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Tumor biology
|
Research Institution | National Cancer Center Japan |
Principal Investigator |
Hattori Naoko 国立研究開発法人国立がん研究センター, 研究所, 研究員 (30611090)
|
Project Period (FY) |
2015-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥3,380,000 (Direct Cost: ¥2,600,000、Indirect Cost: ¥780,000)
Fiscal Year 2016: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2015: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Keywords | エピジェネティクス / ヒストン修飾 / 乳腺発がん / Bivalentヒストン修飾 / 発がん感受性 / bivalentヒストン修飾 |
Outline of Final Research Achievements |
To reveal the molecular mechanism of age-specific cancer susceptibility of mammary glands, I investigated the involvement of bivalent histone modification. ChIP-chip analysis of H3K4me3 and H3K27me3 using rat mammary epithelial cells showed that 91 genes were identified as the bivalent genes in sensitive period. Among the 91 genes, 7 genes were methylated in rat mammary carcinomas, and 4 genes did not express in normal mammary epithelial cells. The human homolog of one gene was known as a tumor suppressor gene that is methylation-silenced in breast cancer. I identified the sensitive period-specific bivalent genes in mammary gland, which were methylated in mammary carcinoma, suggesting that bivalent modification might be a seed of DNA methylation during carcinogenesis.
|
Report
(3 results)
Research Products
(1 results)